TRAILblazing Strategies for Cancer Treatment

In the late 1990s, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF-family, started receiving much attention for its potential in cancer therapy, due to its capacity to induce apoptosis selectively in tumour cells in vivo. TRAIL binds to its membrane-bound d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Kretz, Anna-Laura, Trauzold, Anna, Hillenbrand, Andreas, Knippschild, Uwe, Henne-Bruns, Doris, von Karstedt, Silvia, Lemke, Johannes
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521007/
https://ncbi.nlm.nih.gov/pubmed/30935038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11040456
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars